Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil Musilek

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
ACS Medicinal Chemistry Letters|June 17, 2026
Development of Novel 17β-HSD10 Inhibitors and Their Evaluation in an <i>In Vitro</i> Model of Alzheimer's DiseaseMarketa Sedlacek Miskerikova, Aneta Houfkova, Marketa Benkova, et al.
Toxicology Mechanisms and Methods|July 20, 2017
In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxicationMaria Arshad, Muhammad Qaiser Fatmi, Kamil Musilek, et al.
International Journal of Biological Macromolecules|December 4, 2013
Interaction of cholinesterase modulators with DNA and their cytotoxic activityJana Janockova, Zuzana Gulasova, Jana Plsikova, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 4, 2018
Dose-response modeling of reactivating potency of oximes K027 and K203 against a direct acetylcholinesterase inhibitor in rat erythrocytesEvica Antonijevic, Kamil Musilek, Kamil Kuca, et al.
Pharmacology & Therapeutics|August 27, 2021
Signal transducer and activator of transcription 3 signaling in tumor immune evasionLuying Zhang, Kamil Kuca, Li You, et al.
European Journal of Medicinal Chemistry|January 18, 2011
Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatmentKamil Musilek, Marketa Komloova, Ondrej Holas, et al.
Bioorganic & Medicinal Chemistry|August 12, 2009
Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agentHee Chun Jeong, No-Joong Park, Chong Hak Chae, et al.
Journal of Chromatography. A|March 20, 2022
Optimization of gradient reversed phase high performance liquid chromatography analysis of acetaminophen oxidation metabolites using linear and non-linear retention modelJana Vanova, David Malinak, Rudolf Andrys, et al.
Archives of Toxicology|September 2, 2016
SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticidesLukas Gorecki, Jan Korabecny, Kamil Musilek, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Synthesis and Evaluation of Halogenated Pralidoximes in Reactivation of Organophosphate-Inhibited CholinesterasesKarolina Knittelova, Eliska Prchalova, Adela Fuchsova, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
ACS Medicinal Chemistry Letters|June 17, 2026
Development of Novel 17β-HSD10 Inhibitors and Their Evaluation in an <i>In Vitro</i> Model of Alzheimer's DiseaseMarketa Sedlacek Miskerikova, Aneta Houfkova, Marketa Benkova, et al.
Toxicology Mechanisms and Methods|July 20, 2017
In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxicationMaria Arshad, Muhammad Qaiser Fatmi, Kamil Musilek, et al.
International Journal of Biological Macromolecules|December 4, 2013
Interaction of cholinesterase modulators with DNA and their cytotoxic activityJana Janockova, Zuzana Gulasova, Jana Plsikova, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 4, 2018
Dose-response modeling of reactivating potency of oximes K027 and K203 against a direct acetylcholinesterase inhibitor in rat erythrocytesEvica Antonijevic, Kamil Musilek, Kamil Kuca, et al.
Pharmacology & Therapeutics|August 27, 2021
Signal transducer and activator of transcription 3 signaling in tumor immune evasionLuying Zhang, Kamil Kuca, Li You, et al.
European Journal of Medicinal Chemistry|January 18, 2011
Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatmentKamil Musilek, Marketa Komloova, Ondrej Holas, et al.
Bioorganic & Medicinal Chemistry|August 12, 2009
Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agentHee Chun Jeong, No-Joong Park, Chong Hak Chae, et al.
Journal of Chromatography. A|March 20, 2022
Optimization of gradient reversed phase high performance liquid chromatography analysis of acetaminophen oxidation metabolites using linear and non-linear retention modelJana Vanova, David Malinak, Rudolf Andrys, et al.
Archives of Toxicology|September 2, 2016
SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticidesLukas Gorecki, Jan Korabecny, Kamil Musilek, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Synthesis and Evaluation of Halogenated Pralidoximes in Reactivation of Organophosphate-Inhibited CholinesterasesKarolina Knittelova, Eliska Prchalova, Adela Fuchsova, et al.
Pageof 20